| Literature DB >> 33500453 |
D R Marinowic1,2,3,4,5, G Zanirati1,3, F V F Rodrigues1,3, M V C Grahl1,2, A M Alcará1,3, D C Machado1,2,4,5, J C Da Costa6,7,8,9.
Abstract
Phylogenetic analysis has demonstrated that the etiologic agent of the 2020 pandemic outbreak is a betacoronavirus named SARS-CoV-2. For public health interventions, a diagnostic test with high sensitivity and specificity is required. The gold standard protocol for diagnosis by the Word Health Organization (WHO) is RT-PCR. To detect low viral loads and perform large-scale screening, a low-cost diagnostic test is necessary. Here, we developed a cost-effective test capable of detecting SARS-CoV-2. We validated an auxiliary protocol for molecular diagnosis with the SYBR Green RT-PCR methodology to successfully screen negative cases of SARS-CoV-2. Our results revealed a set of primers with high specificity and no homology with other viruses from the Coronovideae family or human respiratory tract pathogenic viruses, presenting with complementarity only for rhinoviruses/enteroviruses and Legionella spp. Optimization of the annealing temperature and polymerization time led to a high specificity in the PCR products. We have developed a more affordable and swift methodology for negative SARS-CoV-2 screening. This methodology can be applied on a large scale to soften panic and economic burden through guidance for isolation strategies.Entities:
Year: 2021 PMID: 33500453 PMCID: PMC7838253 DOI: 10.1038/s41598-021-81245-0
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379